Anti Fungal Drugs Market, By Drug Type, By Indication, By Dosage Form, By Distribution Channel, By Geography
상품코드:1812491
리서치사:Coherent Market Insights
발행일:2025년 08월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 항진균제 시장은 2025년 150억 달러로 추정되며, 2023년까지 190억 8,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 연평균 성장률(CAGR)은 3.5%로 성장할 전망입니다.
분석 범위
분석 상세
기준연도
2024년
시장 규모(2025년)
150억 달러
실적 데이터
2020-2024년
예측 기간
2025-2032년
예측기간 CAGR(2025-2032년)
3.50%
예측 금액(2032년)
190억 8,000만 달러
항진균제는 개인의 곰팡이 감염을 치료하는 데 사용됩니다. 곰팡이성 손발톱 감염, 백선과 같은 일반적인 곰팡이 감염은 일반적으로 신체의 외부 표면에서 발생하지만, 특정 침습성 곰팡이 감염은 신체 조직 또는 폐 및 뇌와 같은 내장에서 발생합니다. 진균 감염은 보통 HIV/AIDS 환자 등 면역력이 약한 사람에게 많이 보입니다. 또한 화학요법을 받은 환자는 침습성 곰팡이증에 걸리기 쉽습니다. 항진균제는 곰팡이 세포를 죽이거나 증식을 억제하여 곰팡이 감염에 작용합니다. 항진균제는 외용 항진균제, 경구 항진균제, 정맥내 항진균제, 질내 항진균 페서리로 크게 나뉩니다.
시장 역학
시장의 주요 기업은 시장에서의 존재감을 높이기 위해 제휴 및 계약 등의 성장 전략에 주력하고 있습니다. 예를 들어, 2017년 6월 바이오 의약품 회사인 Basilea Pharmaceutica Ltd.는 Pfizer, Inc. 및 Avir Pharma, Inc.와 Beasilea의 항진균 치료제 판매권 계약을 체결했습니다. Pfizer는 러시아, 이스라엘, 유럽(북유럽 제외), 튀르키예 등의 지역에서 생명을 위협하는 침습성 곰팡이 감염증의 치료제을 제조 및 판매합니다.
마찬가지로 시장의 주요 기업은 제품 포트폴리오를 확대하기 위해 R&D 등 다양한 사업 전략에 주력하고 있습니다. 의약품 개발 증가는 이 시장의 성장을 가속할 것으로 예측됩니다. 예를 들어, 2019년 1월, 바이오테크놀러지 기업인 SCYNEXIS, Inc.는 진행중인 FURI 시험의 첫 번째 중간 효율 분석에서 좋은 중간 결과를 발표했습니다. 이 새로운 치료제의 개발은 항진균 치료를 적응시킵니다.
이 보고서의 주요 특징
본 보고서는 세계 항진균제 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모·CAGR을 제공합니다.
또한 각 부문의 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
또한 시장 성장 촉진요인 및 억제요인과 기회, 신제품의 출시와 승인, 시장 동향, 지역별 전망, 주요기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
세계 항진균제 시장의 주요 기업 프로파일은 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개 변수를 기반으로 게시됩니다.
이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
'세계 항진균제 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
이해관계자는 세계 항진균제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
분석 목적
전제조건
약어
제2장 시장 전망
보고서 설명
시장 정의와 범위
주요 요약
제3장 시장 역학, 규제 및 동향 분석
시장 역학
성장 촉진요인
억제요인
시장 기회
영향 분석
최근 테스트 시작
역학
기업 인수합병(M&A), 사업 제휴
규제 시나리오
주요 발전
PEST 분석
제4장 세계의 항진균제 시장, 약제유형별(2020-2032년)
에키노칸디
폴리엔
알릴아민
아졸
기타
제5장 세계의 항진균제 시장 : 적응증별(2020-2032년)
아스페르길루스증
피부사상균증
칸디다증
털곰팡이증
기타
제6장 세계의 항진균제 시장 : 제형별(2020-2032년)
분말
연고
주사
정제
기타
제7장 세계의 항진균제 시장 : 유통 채널별(2020-2032년)
병원 약국
온라인 약국
소매 약국
제8장 세계의 항진균제 시장 : 지역별(2020-2032년)
북미
미국
캐나다
유럽
영국
독일
이탈리아
프랑스
스페인
러시아
기타 유럽
아시아태평양
중국
인도
일본
ASEAN
호주
한국
기타 아시아태평양
라틴아메리카
브라질
멕시코
아르헨티나
기타 라틴아메리카
중동
GCC
이스라엘
기타 중동
아프리카
북아프리카
중앙 아프리카
남아프리카
제9장 경쟁 구도
기업 프로파일
GlaxoSmithKline Plc
Bayer AG
Abbott Laboratories
Merck & Co., Inc.
Glenmark Pharmaceuticals Limited
Enzon Pharmaceuticals, Inc.
Pfizer Inc.
Gilead Sciences, Inc.
Sanofi SA
Astellas Pharma, Inc.
Alembic Pharmaceuticals Limited
SCYNEXIS, Inc.
제10장 섹션
참고문헌
분석 방법
JHS
영문 목차
영문목차
Anti Fungal Drugs Market is estimated to be valued at USD 15 Bn in 2025 and is expected to reach USD 19.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 15 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
3.50%
2032 Value Projection:
USD 19.08 Bn
Antifungal drugs are used to treat fungal infections in individuals. Common fungal infections such as fungal nail infection, and ringworm etc. usually occur on the external surface of the body, while certain invasive fungal infections occur inside the body tissues or inside internal organs such as lungs and brain. Fungal infection is usually associated with individuals having weak immune system, such as people suffering from HIV/AIDS. Moreover, patients undergoing chemotherapy are susceptible to invasive fungal infections. Antifungal drugs act against the fungal infections by either killing the fungal cells or by inhibiting their growth. Antifungal drugs are broadly classified as topical antifungals, oral antifungals, intravenous antifungals, and intravaginal antifungal pessaries.
Market Dynamics
Major players in the market are focused on growth strategies such as collaborations and agreements in order to enhance their market presence. For instance, in June 2017, Basilea Pharmaceutica Ltd., a biopharmaceutical company, entered into an agreement with Pfizer, Inc. and Avir Pharma, Inc. for the distribution rights of Beasilea's antifungal treatments. Pfizer will manufacture and distribute drugs for the treatment of life-threatening invasive mold infections in regions like Russia, Israel, Europe (excluding Nordics), and Turkey.
Similarly, key players in the market are focused on various business strategies such as research and development in order to expand their product portfolio. Increasing drug development is expected to drive growth of this market. For instance, in January 2019, SCYNEXIS, Inc., a biotechnology company, announced positive interim result from their first interim efficiency analysis of an ongoing FURI study. The development of this novel treatment is indicated for antifungal treatment.
Key features of the study
This report provides an in-depth analysis of global antifungal drugs market, provides market size (USD Bn), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
It profiles leading players in the global antifungal drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A., and Astellas Pharma, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
The global antifungal drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antifungal drugs market.
Market Segmentation
By Drug Type
Echinocandins
Polyenes
Allylamines
Azoles
Others
By Application
Neurosurgery
Plastic Surgery
Cardiovascular Surgery
Obstetrics & Gynecology
Others
By Indication
Aspergillosis
Dermatophytosis
Candidiasis
Mucormycosis
Others
By Dosage Form
Powders
Ointments
Injections
Tablets
Others
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
GlaxoSmithKline Plc
Bayer AG
Abbott Laboratories
Merck & Co., Inc.
Glenmark Pharmaceuticals Limited
Enzon Pharmaceuticals, Inc.
Pfizer Inc.
Gilead Sciences, Inc.
Sanofi S.A.
Astellas Pharma, Inc.
Alembic Pharmaceuticals Limited
SCYNEXIS, Inc.
Table of Contents
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Indication
Market Snippet, By Dosage Form
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Anti Fungal Drugs Market, By Drug Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Echinocandins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Segment Trends
Polyenes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Segment Trends
Allylamines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Segment Trends
Azoles
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Segment Trends
5. Global Anti Fungal Drugs Market, By Indication, 2020 - 2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Aspergillosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Segment Trends
Dermatophytosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Segment Trends
Candidiasis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Segment Trends
Mucormycosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Segment Trends
6. Global Anti Fungal Drugs Market, By Dosage Form, 2020 - 2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Powders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Ointments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Injections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Tablets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
7. Global Anti Fungal Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
8. Global Anti Fungal Drugs Market, By Region, 2020 - 2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
North America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
